Copyright: ©Author(s) 2026.
World J Cardiol. May 26, 2026; 18(5): 119100
Published online May 26, 2026. doi: 10.4330/wjc.v18.i5.119100
Published online May 26, 2026. doi: 10.4330/wjc.v18.i5.119100
Figure 2 Risk of bias assessment of included studies.
A: Risk of bias in non-randomized studies of interventions scale graph for included observational studies; B: Traffic plot for included observational studies; C: Risk of bias 2.0 tool graph for included observational studies; D: Traffic plot for included observational studies.
- Citation: Sohail R, Khan Z, Shah HH, Khattak R, Khan A, Chaudhry S, Khan U, Mansoor H, Namal F, Orciuolo J, Desai S, Singh M. Cardiovascular safety of proton pump inhibitors in post-percutaneous coronary intervention patients receiving dual antiplatelet therapy: A meta-analysis. World J Cardiol 2026; 18(5): 119100
- URL: https://www.wjgnet.com/1949-8462/full/v18/i5/119100.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i5.119100